 Home > Drugs > Dextran 40

Dextran 40

Indication

Suitable for hypovolemic shock and thromboembolic diseases.

Shock

Manufacturer

Founded in:

1999-10-14
Address:

Wuhan Miaoshan Community Special No. 1 Wuhan Pharmaceutical Industrial Park
Tax NO.:

91420115717919268T
Registered Funds:

132.06 million yuan
Website:

Log in to view
Email:

Log in to view

Other Drugs of Wuhan Jiu'an Pharmaceutical Co., Ltd.

Glycine Dopamine Hydrochloride Injection Oxytetracycline Hydrochloride Tablets Compound Sodium Lactate Glucose Injection Bumetanide injection Metronidazole Sodium Chloride Injection



Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)

National-level Technology-based SME
China's Top 100 Industrial Digitalization Enterprises List
The Drafting Unit of the "Specification for Operation and Management of Self-build Cross-border E-commerce Website" of the CCPIT
High-Tech Enterprise

鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Digital Technology Co., Ltd.



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.